Key result
Lovastatin protects human endothelial cells from radiation-induced death without impairing DNA repair.
Why the study?
Does lovastatin protect primary human umbilical vein endothelial cells from ionizing radiation-induced cytotoxicity?
Does lovastatin protect primary human umbilical vein endothelial cells from ionizing radiation-induced cytotoxicity?
Lovastatin protects human endothelial cells from radiation-induced cell death by modulating stress responses without impairing DNA double-strand break repair, suggesting potential utility in mitigating radiation therapy side effects.
Answers are grounded in this paper and cite their sources.
May support endothelial radioprotection during radiotherapy; leaves open clinical translation and effects on tumor control.
PURPOSE: 3-hydroxy-3-methylglutaryl CoA reductase inhibitors (statins) are frequently used lipid-lowering drugs. Moreover, they are reported to exert pleiotropic effects on cellular stress responses, proliferation, and apoptosis. Whether statins affect the sensitivity of primary human cells to ionizing radiation (IR) is still unknown. The present study aims at answering this question. EXPERIMENTAL DESIGN: The effect of lovastatin on IR-provoked cytotoxicity was analyzed in primary human umbilical vein endothelial cells (HUVEC). To this end, cell viability, proliferation, and apoptosis as well as DNA damage-related stress responses were investigated. RESULTS: The data show that lovastatin protects HUVEC from IR-induced cell death. Lovastatin did not confer radioresistance to human fibroblasts. The radioprotective, antiapoptotic effect of lovastatin was observed at low, physiologically relevant dose level (1 micromol/L). Lovastatin affected various IR-induced stress responses in HUVEC: It attenuated the increase in p53/p21 protein level and impaired the activation of nuclear factor-kappaB, Chk-1, and Akt kinase but did not inhibit extracellular signal-regulated kinase activation. Exposure of HUVEC to IR did not change the level of Bax and Bcl-2 and did not cause activation of caspase-3, indicating that radioprotection by lovastatin does not depend on the modulation of the mitochondrial death pathway. Also, IR-induced DNA double-strand break formation and repair were not influenced by lovastatin. CONCLUSIONS: The data show that lovastatin has multiple inhibitory effects on IR-stimulated DNA damage-dependent stress responses in HUVEC. Because lovastatin causes radioresistance, it might be useful in the clinic for attenuating side effects of radiation therapy that are related to endothelial cell damage.
No takes yet. Share an insight, caveat, or question.
Nübel et al. (2006) studied Ionizing radiation-induced endothelial cell damage. Lovastatin was evaluated on Ionizing radiation-induced cell death. Lovastatin protected primary human umbilical vein endothelial cells from ionizing radiation-induced cell death at a dose of 1 micromol/L without impairing DNA double-strand break repair.
Synapse has enriched 10 related papers. Consider them for comparative context: